Table 1.
HIV antibody detection* | |||||
Positive (n=82) | Negative (n=192) | Sensitivity 95% CI | Specificity 95% CI | Cohen’s kappa statistic | |
Multiplex HIV | 81 | 192 | 98.8% (93.40 – 100%) | 100% (98.1–100%) | 0.99 (0.97–1) |
INSTI HIV | 81 | 192 | |||
Treponema pallidum antibody detection** | |||||
Positive (n=74) | Negative (n=200) | Sensitivity 95% CI | Specificity 95% CI | Cohen’s kappa statistic | |
Multiplex TP | 42 | 197 | 56.8% (44.7– 68.2%) | 98.5% (95.7–99.7%) | 0.63 (0.52–0.74) |
Syphilis Healthcheck | 54 | 194 | 73% (61.4–82.6%) | 97% (93.6–98.9%) | 0.75 (0.56–0.86) |
Reference tests: Abbott ARCHITECT HIV Ag/Ab Combo; 4th generation ADVIA Centaur XP HIV-1/O/2 Antigen/Antibody
Reference tests: Serodia TPPA, Fujirebio Inc, PA, USA; TPEIA Bioplex 2200, Bio-Rad Industries, CA, USA